• 30 NOVEMBER 2016

Divestment of TEVA businesses

Zepos & Yannopoulos advised Teva on the corporate and regulatory matters pertinent to the divestment of certain businesses which was dictated by the Commitments defined by the EU Commission Decision on the acquisition of Allergan by Teva. Teva Pharmaceutical Industries Ltd is a leading global pharmaceutical company, listed on NYSE, and engaged in the development, production and marketing of affordable generic drugs, as well as of innovative and specialty pharmaceuticals and active pharmaceutical ingredients. Zepos & Yannopoulos advised on the regulatory and corporate aspects of the transaction pertaining to the jurisdiction of Greece.

Taylor Wessing acted as international legal counsel for TEVA in this divestment.

Leading lawyers: Julia Pournara and Thomas Rozis.